Stayble is a clinical stage pharmaceutical company developing the injectable treatment STA363 for disc hernia. The treatment is aimed at patients whose back pain persists after physiotherapy and painkillers. The injection is given once, and the effect is expected to remain throughout the entirety of the patient’s life and to require minimal rehabilitation. The Company’s focus is set upon the continued clinical development of the ongoing clinical phase 1b study. Stayble’s vision is to develop STA363 as a new standard treatment for patients suffering from pain caused by disc hernia.

Family business where I work with internal strategies, customer relations, offerings, marketing material and graphical design. In addition to this I have also worked with external clients regarding education within IT software and development of business strategies.

iliod therapeutics developed a novel biological pharmaceutical to treat local infections. The project was terminated after placebo demonstrating better efficacy than active treatment in a pre-clinical model. iliod was run as a collaboration with researchers from Karolinska Institute and Encubator AB.My responsibility was strategic planning and development of the project, design of animal models, amendment of patents, financing activities and interaction with medical experts, patients and potential customers.

Investours is an NGO with focus on providing micro entrepreneurs in Dar Es Salaam interest free micro loans. My responsibility was continued development of the offer to the entrepreneurs, strategic development plans and market analysis for further expansion to other parts of Tanzania

Working as an indoor salesman with responsibility for incoming orders, production planning and outgoing logistics.

Working as an indoor salesman with responsibility for incoming orders, production planning and outgoing logistics.